Schedule of Investments
ARK Innovation ETF
October 31, 2021 (Unaudited)
Investments | Shares | Value | ||||||
COMMON STOCKS–99.9% | ||||||||
Automobiles - 11.2% | ||||||||
Tesla, Inc.* | 2,147,614 | $ | 2,392,441,996 | |||||
Biotechnology - 18.4% | ||||||||
Beam Therapeutics, Inc.*† | 5,591,935 | 496,396,070 | ||||||
CRISPR Therapeutics AG (Switzerland)*† | 5,911,483 | 539,895,742 | ||||||
Editas Medicine, Inc.*† | 3,983,953 | 146,290,754 | ||||||
Exact Sciences Corp.* | 6,650,071 | 633,219,760 | ||||||
Fate Therapeutics, Inc.*† | 6,103,559 | 328,371,474 | ||||||
Ginkgo Bioworks Holdings, Inc.* | 19,824,528 | 273,974,977 | ||||||
Intellia Therapeutics, Inc.*† | 4,567,878 | 607,436,417 | ||||||
Invitae Corp.*† | 15,632,496 | 414,261,144 | ||||||
Iovance Biotherapeutics, Inc.* | 5,342,913 | 129,886,215 | ||||||
Twist Bioscience Corp.* | 1,537,766 | 182,686,601 | ||||||
Veracyte, Inc.*† | 3,751,118 | 179,603,530 | ||||||
Total Biotechnology | 3,932,022,684 | |||||||
Capital Markets - 7.3% | ||||||||
Coinbase Global, Inc., Class A* | 3,946,923 | 1,260,726,145 | ||||||
Robinhood Markets, Inc., Class A* | 8,788,602 | 307,337,412 | ||||||
Total Capital Markets | 1,568,063,557 | |||||||
Diversified Consumer Services - 0.7% | ||||||||
2U, Inc.*† | 5,194,836 | 153,455,455 | ||||||
Diversified Telecommunication - 1.3% | ||||||||
Iridium Communications, Inc.*† | 6,760,374 | 274,133,166 | ||||||
Electronic Equipment, Instruments & Components - 0.5% | ||||||||
Trimble, Inc.* | 1,354,924 | 118,379,710 | ||||||
Entertainment - 9.9% | ||||||||
Roku, Inc.* | 3,557,689 | 1,084,739,376 | ||||||
Skillz, Inc.* | 13,291,935 | 148,603,833 | ||||||
Spotify Technology SA* | 3,074,867 | 889,866,510 | ||||||
Total Entertainment | 2,123,209,719 | |||||||
Health Care Equipment & Supplies - 0.3% | ||||||||
Cerus Corp.*† | 10,190,062 | 67,254,409 | ||||||
Health Care Providers & Services - 0.8% | ||||||||
Signify Health, Inc., Class A*† | 10,147,733 | 163,074,069 | ||||||
Health Care Technology - 6.9% | ||||||||
Teladoc Health, Inc.*† | 9,795,709 | 1,465,340,109 | ||||||
Hotels Restaurants & Leisure - 2.4% | ||||||||
DraftKings, Inc., Class A* | 10,862,777 | 506,096,780 | ||||||
Interactive Media & Services - 5.8% | ||||||||
Twitter, Inc.* | 10,101,930 | 540,857,332 | ||||||
Zillow Group, Inc., Class C* | 6,795,674 | 704,235,697 | ||||||
Total Interactive Media & Services | 1,245,093,029 | |||||||
IT Services - 10.2% | ||||||||
Shopify, Inc., Class A (Canada)* | 513,993 | 753,888,953 | ||||||
Square, Inc., Class A* | 3,190,810 | 812,061,145 | ||||||
Twilio, Inc., Class A* | 2,123,908 | 618,821,835 | ||||||
Total IT Services | 2,184,771,933 | |||||||
Life Sciences Tools & Services - 3.6% | ||||||||
10X Genomics, Inc., Class A* | 2,104,847 | 339,448,676 | ||||||
Berkeley Lights, Inc.*† | 4,651,225 | 108,140,981 | ||||||
Compugen Ltd. (Israel)*† | 5,361,008 | 34,792,942 | ||||||
NanoString Technologies, Inc.* | 53,037 | 2,561,687 | ||||||
Pacific Biosciences of California, Inc.* | 10,309,807 | 273,003,689 | ||||||
Total Life Sciences Tools & Services | 757,947,975 | |||||||
Machinery - 0.1% | ||||||||
Proto Labs, Inc.* | 210,039 | 12,562,433 | ||||||
Road & Rail - 1.3% | ||||||||
TuSimple Holdings, Inc., Class A* | 7,054,774 | 275,982,759 | ||||||
Software - 18.7% | ||||||||
DocuSign, Inc.* | 1,182,696 | 329,132,470 | ||||||
Materialise NV (Belgium)*†(a) | 3,083,046 | 74,393,900 | ||||||
PagerDuty, Inc.*† | 6,852,565 | 286,094,589 | ||||||
Palantir Technologies, Inc., Class A* | 23,756,171 | 614,809,705 | ||||||
UiPath, Inc., Class A* | 12,402,796 | 623,240,499 | ||||||
Unity Software, Inc.* | 7,419,293 | 1,122,613,224 | ||||||
Zoom Video Communications, Inc., Class A* | 3,392,322 | 931,701,237 | ||||||
Total Software | 3,981,985,624 | |||||||
Technology Hardware, Storage & Peripherals - 0.5% | ||||||||
Stratasys Ltd.*† | 3,645,140 | 114,967,716 | ||||||
Total Common Stocks (Cost $21,413,584,961) | 21,336,783,123 | |||||||
MONEY MARKET FUND–0.2% | ||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03% (b) (Cost $35,636,738) | 35,636,738 | 35,636,738 | ||||||
Total Investments–100.1% (Cost $21,449,221,699) | 21,372,419,861 | |||||||
Liabilities in Excess of Other Assets–(0.1)% | (11,964,954) | |||||||
Net Assets–100.0% | $ | 21,360,454,907 |
Schedule of Investments (continued)
ARK Innovation ETF
October 31, 2021 (Unaudited)
Affiliated Issuer Transactions
A summary of the Fund’s period to date transactions with companies which are or were affiliated issuers during the period are as follows:
Value ($) at 7/31/2021 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 10/31/2021 | Value ($) at 10/31/2021 | ||||||||||||||||||||||||
Common Stocks — 25.5% | ||||||||||||||||||||||||||||||||
Biotechnology — 12.7% | ||||||||||||||||||||||||||||||||
Beam Therapeutics, Inc. | ||||||||||||||||||||||||||||||||
429,666,220 | 186,377,578 | (107,210,079 | ) | 25,075,038 | (37,512,687 | ) | – | – | 5,591,935 | 496,396,070 | ||||||||||||||||||||||
CRISPR Therapeutics AG | ||||||||||||||||||||||||||||||||
590,141,202 | 229,786,929 | (127,795,139 | ) | 55,155,822 | (207,393,072 | ) | – | – | 5,911,483 | 539,895,742 | ||||||||||||||||||||||
Editas Medicine, Inc. | ||||||||||||||||||||||||||||||||
179,157,870 | 37,996,245 | (56,245,975 | ) | 22,454,892 | (37,072,278 | ) | – | – | 3,983,953 | 146,290,754 | ||||||||||||||||||||||
Fate Therapeutics, Inc. | ||||||||||||||||||||||||||||||||
368,294,731 | 211,549,852 | (86,335,388 | ) | 808,269 | (165,945,990 | ) | – | – | 6,103,559 | 328,371,474 | ||||||||||||||||||||||
Intellia Therapeutics, Inc. | ||||||||||||||||||||||||||||||||
588,966,306 | 197,986,103 | (149,133,213 | ) | 119,241,454 | (149,624,233 | ) | – | – | 4,567,878 | 607,436,417 | ||||||||||||||||||||||
Invitae Corp. | ||||||||||||||||||||||||||||||||
331,826,516 | 201,361,213 | (88,918,140 | ) | 37,522,216 | (67,530,661 | ) | – | – | 15,632,496 | 414,261,144 | ||||||||||||||||||||||
Iovance Biotherapeutics, Inc. | ||||||||||||||||||||||||||||||||
189,057,134 | 22,227,761 | (94,060,269 | ) | (70,907,045 | ) | 83,568,634 | – | – | – | – | ||||||||||||||||||||||
Veracyte, Inc. | ||||||||||||||||||||||||||||||||
146,417,966 | 57,306,558 | (36,543,141 | ) | 15,585,964 | (3,163,817 | ) | – | – | 3,751,118 | 179,603,530 | ||||||||||||||||||||||
Diversified Consumer Services — 0.7% | ||||||||||||||||||||||||||||||||
2U, Inc. | ||||||||||||||||||||||||||||||||
223,797,134 | 39,359,420 | (38,952,937 | ) | 14,553,322 | (85,301,484 | ) | – | – | 5,194,836 | 153,455,455 | ||||||||||||||||||||||
Diversified Telecommunication — 1.3% | ||||||||||||||||||||||||||||||||
Iridium Communications, Inc. | ||||||||||||||||||||||||||||||||
351,317,071 | 49,876,705 | (113,778,996 | ) | 1,248,137 | (14,529,751 | ) | – | – | 6,760,374 | 274,133,166 | ||||||||||||||||||||||
Health Care Equipment & Supplies — 0.3% | ||||||||||||||||||||||||||||||||
Cerus Corp. | ||||||||||||||||||||||||||||||||
61,502,127 | 2,729,467 | (15,090,839 | ) | 1,088,932 | 17,024,722 | – | – | 10,190,062 | 67,254,409 | |||||||||||||||||||||||
Health Care Providers & Services — 0.8% | ||||||||||||||||||||||||||||||||
Signify Health, Inc. | ||||||||||||||||||||||||||||||||
– | 256,374,134 | (26,210,201 | ) | 102,380 | (67,192,244 | ) | – | – | 10,147,733 | 163,074,069 | ||||||||||||||||||||||
Health Care Technology — 6.8% | ||||||||||||||||||||||||||||||||
Teladoc Health, Inc. | ||||||||||||||||||||||||||||||||
1,309,104,544 | 401,529,345 | (271,547,277 | ) | 2,608,581 | 23,644,916 | – | – | 9,795,709 | 1,465,340,109 | |||||||||||||||||||||||
Life Sciences Tools & Services — 0.7% | ||||||||||||||||||||||||||||||||
Berkeley Lights, Inc. | ||||||||||||||||||||||||||||||||
158,277,143 | 66,532,052 | (27,566,356 | ) | 829,375 | (89,931,233 | ) | – | – | 4,651,225 | 108,140,981 | ||||||||||||||||||||||
Compugen Ltd. | ||||||||||||||||||||||||||||||||
43,591,664 | 1,473,809 | (8,164,870 | ) | 2,501,960 | (4,609,621 | ) | – | – | 5,361,008 | 34,792,942 | ||||||||||||||||||||||
Machinery — 0.0% | ||||||||||||||||||||||||||||||||
Proto Labs, Inc. | ||||||||||||||||||||||||||||||||
155,624,215 | 12,162,066 | (137,729,546 | ) | (111,173,752 | ) | 93,679,450 | – | – | – | – | ||||||||||||||||||||||
Software — 1.7% | ||||||||||||||||||||||||||||||||
Materialise NV | ||||||||||||||||||||||||||||||||
80,375,733 | 2,829,913 | (15,857,307 | ) | 1,343,291 | 5,702,270 | – | – | 3,083,046 | 74,393,900 | |||||||||||||||||||||||
PagerDuty, Inc. | ||||||||||||||||||||||||||||||||
224,620,189 | 118,310,673 | (59,408,117 | ) | 24,578,969 | (22,007,125 | ) | – | – | 6,852,565 | 286,094,589 |
Schedule of Investments (continued)
ARK Innovation ETF
October 31, 2021 (Unaudited)
Value ($) at 7/31/2021 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 10/31/2021 | Value ($) at 10/31/2021 | ||||||||||||||||||||||||||
Technology Hardware, Storage & Peripherals — 0.5% | ||||||||||||||||||||||||||||||||||
Stratasys Ltd. | ||||||||||||||||||||||||||||||||||
81,818,214 | 8,841,637 | (19,913,202 | ) | 3,226,244 | 40,994,823 | – | – | 3,645,140 | 114,967,716 | |||||||||||||||||||||||||
$ | 5,513,555,979 | $ | 2,104,611,460 | $ | (1,480,460,992 | ) | $ | 145,844,049 | $ | (687,199,381 | ) | $ | – | $ | – | 111,224,120 | $ | 5,453,902,467 |
* | Non-income producing security |
† | Affiliated security |
(a) | Less than 0.05% |
(b) | American Depositary Receipt |
(c) | Rate shown represents annualized 7-day yield as of October 31, 2021. |
Schedule of Investments (continued)
ARK Innovation ETF
October 31, 2021 (Unaudited)
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 — Quoted prices in active markets for identical assets.
• Level 2 — Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 — Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of October 31, 2021, based upon the three levels defined above:
ARK Innovation ETF | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Assets | ||||||||||||||||
Common Stocks‡ | $ | 21,336,783,123 | $ | – | $ | – | $ | 21,336,783,123 | ||||||||
Money Market Fund | 35,636,738 | – | – | 35,636,738 | ||||||||||||
Total | $ | 21,372,419,861 | $ | – | $ | – | $ | 21,372,419,861 |
‡ | Please refer to the Schedule of Investments to view securities segregated by industry type. |